Ottawa, Sept. 05, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister company of Precedence Research, the global oncology molecular diagnostics market was estimated at USD ...

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: ...

Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...

Over the past decade, the landscape of cancer research has undergone a remarkable transformation. Driven by rapid advancements in high-throughput omics ...

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

Molbio Diagnostics Ltd., the Goa-based molecular diagnostics company known for its Truenat testing platform, has filed a draft red herring prospectus (DRHP) with the Securities and Exchange Board of ...

Goa-based Molbio Diagnostics Limited, backed by Temasek and Motilal Oswal Private Equity, has submitted draft documents to the Securities and Exchange Board of India (SEBI) to raise capital through an ...

Temasek Holdings subsidiary, and Motilal Oswal Private Equity-backed Molbio Diagnostics, the Goa-based point-of-care molecular diagnostics platform operator, has filed preliminary papers with the SEBI ...